XML 33 R27.htm IDEA: XBRL DOCUMENT

Sale of Future Royalties - Additional Information (Details) - USD ($)		1 Months Ended	9 Months Ended
	Jan. 19, 2021	Jan. 31, 2021	Sep. 30, 2024
Sale Of Future Royalties [Line Items]
Liability related to the sale of future royalties	$ 60,000,000
Annual interest rate on interest expense	10.50%
Non-cash other income			$ 26,600,000
Initial upfront payment received			$ 60,000,000
Seltorexant \| Royalty Pharma
Sale Of Future Royalties [Line Items]
Upfront payment for royalty interest sold	$ 60,000,000	$ 60,000,000
Initial upfront payment amortized interest expense potential milestone payments received	0
Additional milestone payments	95,000,000
Potential future milestone payments received	$ 60,000,000